CD274 and esophageal squamous cell carcinoma: Over the past three years, various large-scale RCTs have produced results indicating that multiple ICIs combined with chemotherapy regimens can be chosen for the treatment of advanced ESCC patients without PD-L1 selection, with PD-L1 expression ≥1 or PD-L1 expression ≥10.